MarketCap
Facebook
X
Telegram
Entasis Therapeutics Holdings Balance Sheet 2021-2011 | ETTX
Brief overview of Entasis Therapeutics Holdings 's financial position
The review uses the five latest available annual reports between 2017 and 2021.
Assets declined from $58.8 million to $40.9 million, or -30.4%. The contraction calls for context such as disposals, restructuring or weaker operations.
Asset growth of -30.4% came with a -1.7% rise in liabilities. Financial leverage became more prominent.
The equity ratio reached 76.3% from -94.9%. A high capital share reduces dependence on liabilities.
Cash accounts for 79% of assets versus 93.7% initially. The change indicates the degree of financial flexibility.
The balance sheet carries negative retained earnings of -$231.6 million. The figure may result from accumulated losses or an active capital return policy.
Balance sheet takeaway
Entasis Therapeutics Holdings 's balance sheet presents a mixed picture: strengths coexist with a limited cushion. Future capital and debt trends are particularly important.
Annual Balance Sheet Entasis Therapeutics Holdings
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | -51.9 M | -14.2 M | - | -55.1 M | -26.3 M | - | - | - | - | - |
Long Term Debt |
- | 704 K | 1.32 M | - | - | - | - | - | - | - | - |
Long Term Debt Current |
704 K | 617 K | 506 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | 704 K | 1.32 M | 175 K | 105 M | 48.4 M | - | - | - | - | - |
Total Current Liabilities |
9.71 M | 8.56 M | 7.56 M | 6.22 M | 9.83 M | - | - | - | - | - | - |
Total Liabilities |
9.71 M | 9.27 M | 8.88 M | 6.39 M | 9.87 M | 53.4 M | - | - | - | - | - |
Retained Earnings |
-232 M | -184 M | -134 M | -90.1 M | -57.2 M | -27.2 M | - | - | - | - | - |
Total Assets |
40.9 M | 61.6 M | 51 M | 89.3 M | 58.8 M | 27.1 M | - | - | - | - | - |
Cash and Cash Equivalents |
32.3 M | 53.2 M | 16 M | 49.4 M | 55.1 M | - | - | - | - | - | - |
Book Value |
31.2 M | 52.3 M | 42.2 M | 82.9 M | 48.9 M | -26.3 M | - | - | - | - | - |
Total Shareholders Equity |
31.2 M | 52.3 M | 42.2 M | 82.9 M | -55.8 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Entasis Therapeutics Holdings
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | 3.3 M | - | 183 K | 361 K | 535 K | 704 K | 864 K | 1.02 M | 1.17 M | 1.32 M | 1.46 M | 1.6 M | 1.72 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | 27.4 M | 9.71 M | 9.53 M | 10.5 M | 8.57 M | 9.27 M | 7.73 M | 7.18 M | 6.96 M | 8.88 M | 8.39 M | 8.65 M | 10.7 M | 6.39 M | 9.58 M | 6.39 M | 6.39 M | 9.87 M | 9.87 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | -247 M | -232 M | -220 M | -207 M | -195 M | -184 M | -174 M | -163 M | -149 M | -134 M | -120 M | -116 M | -103 M | -90.1 M | -82 M | -90.1 M | -90.1 M | -57.2 M | -57.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | - | 44.1 M | 40.9 M | 50.8 M | 63.6 M | 52.8 M | 61.6 M | 70 M | 56.5 M | 34.7 M | 51 M | 63.3 M | 66.5 M | 81.3 M | 89.3 M | 100 M | 89.3 M | 89.3 M | 58.8 M | 58.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | 33.5 M | 32.3 M | 44.1 M | 56.4 M | 44.9 M | 53.2 M | 61.2 M | 50.8 M | 17.4 M | 16 M | 15.3 M | 5.2 M | 13.5 M | 49.4 M | 94 M | 49.4 M | 49.4 M | 55.1 M | 55.1 M | - | - | 26.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | - | 16.6 M | 31.2 M | 41.2 M | 53.1 M | 44.3 M | 52.3 M | 62.2 M | 49.3 M | 27.7 M | 42.2 M | 54.9 M | 57.8 M | 70.6 M | 82.9 M | 90.5 M | 82.9 M | 82.9 M | 48.9 M | 48.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | 16.6 M | 31.2 M | 41.2 M | 53.1 M | 44.3 M | 52.3 M | 62.2 M | 49.3 M | 27.7 M | 42.2 M | 54.9 M | 57.8 M | 70.6 M | 82.9 M | 90.5 M | 82.9 M | 82.9 M | -55.8 M | -55.8 M | - | - | -26.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Entasis Therapeutics Holdings , providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
USA
Canada
China
Britain
France
Israel
Germany
Russia
Belgium
Cayman-islands
